Showing results (171-180 of 336) with videos related to
Sort By:
Pageof 34
Japanese Journal of Clinical Oncology|September 28, 2010
Lung cancer working group reportNagahiro Saijo, Masahiro Fukuoka, Sumitra Thongprasert, et al.Journal of Cancer Research and Clinical Oncology|September 25, 2009
Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutationsKimihide Yoshida, Yasushi Yatabe, Jangchul Park, et al.Thoracic Cancer|March 12, 2021
Activity of tarloxotinib-E in cells with EGFR exon-20 insertion mutations and mechanisms of acquired resistanceMasaya Nishino, Kenichi Suda, Takamasa Koga, et al.The Journal of Thoracic and Cardiovascular Surgery|May 3, 2002
A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: the incidence of carcinomatous pleuritis after surgical interventionYukito Ichinose, Ryosuke Tsuchiya, Teruaki Koike, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2009
Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinibTatsuya Katayama, Junichi Shimizu, Kenichi Suda, et al.Annals of Surgical Oncology|May 10, 2015
Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and EmphysemaTakahiro Mimae, Kenji Suzuki, Masahiro Tsuboi, et al.Thoracic Cancer|November 12, 2015
Prognosis and segment-specific nodal spread of primary lung cancer in the right lower lobeKenji Tomizawa, Kenichi Suda, Toshiki Takemoto, et al.Clinical Lung Cancer|October 27, 2021
Intra-tumor and Inter-tumor Heterogeneity in MET Exon 14 Skipping Mutations and Co-mutations in Pulmonary Pleomorphic CarcinomasToshio Fujino, Kenichi Suda, Kazuko Sakai, et al.Lung Cancer (Amsterdam, Netherlands)|July 1, 2008
Immunohistochemical analysis of phosphorylated epidermal growth factor receptor might provide a surrogate marker of EGFR mutationHideki Endoh, Yasunori Ishibashi, Ei Yamaki, et al.Lung Cancer (Amsterdam, Netherlands)|August 30, 2020
Spatial heterogeneity of acquired resistance mechanisms to 1st/2nd generation EGFR tyrosine kinase inhibitors in lung cancerKenichi Suda, Isao Murakami, Keiko Obata, et al.Pageof 34